Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322
NCT07312799
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
41
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
Treatment A(AD-2321)
DRUG:
Treatment B(AD-2322)
DRUG:
Treatment C(AD-2321+AD-2322)
Sponsor
Addpharma Inc.